Meditech is the only Chinese PSA manufacturer in the ACT program initiated by WHO, UN agencies, World Bank, The Global Fund and other international organizations!
The Access to COVID-19 Tools (ACT) Accelerator program was launched on April 24, 2020, to accelerate the development and equitable distribution of COVID-19 diagnostics, treatments and vaccines. The initiative has three pillars: vaccines, therapeutics and diagnostics. The lead organizations for the vaccine pillar are Gavi, Vaccine Alliance, Coalition for Epidemic Preparedness Innovations (CEPI) and WHO. The Wellcome Trust and UNITAID lead the therapeutics, while the Foundation for Innovative New Diagnostics (FIND) and The Global Fund to Fight AIDS, Tuberculosis and Malaria (or simply the Global Fund) lead the diagnostics. In addition to these three pillars, there is A Health Systems and Response Connector pillar dedicated to ensuring these tools reach people.
Meditech has made another leap in the international market. The company will insist on continuous innovation and make contributions to the industry while adapting to the ever-changing market.
Post time: Nov-15-2022